Author

Genevieve Weist

Spark Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

Adam Daniels· 1 shared Apolonia GardneriD· 1 shared Ashley Carter· 1 shared Christin M. HongiD· 1 shared Christine C. WuiD· 1 shared Christine Ott· 1 shared Constance L. CepkoiD· 1 shared Dan Dan LiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Adam Daniels

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

AAV NRF2 Gene Therapy Preserves Retinal Structure and Function in Rodent Models of Oxidative Damage

Apolonia Gardner, Shuai Wang, Adam Daniels, Dan Dan Li, Christine C. Wu, Lucas Lin, Christin M. Hong, Sophia R. Zhao, Richard T. Born, Kamil Kruczek, Genevieve Weist, Laura Barrio Real, Joan Wicks, Mohamad Nayal, Ashley Carter, , Constance L. Cepko

This paper tests AAV8/Best1-Nrf2 gene therapy in rodent models of oxidative stress, showing protection of retinal cells and preservation of visual function.

Molecular Therapy · Feb 6, 2026Peer-reviewedPharmacology & Toxicology